The number elderly patients with psoriasis is steadily increasing in the Western world, nevertheless they are frequently excluded from biologic clinical trials and described as a high-risk group for adverse events. Thus, there is lack of information concerning safety and effectiveness of available treatments for psoriasis in the elderly, particularly about new biologic systemic drugs.
Elderly psoriatic patients under biological therapies: an Italian experience
Rongioletti, FPenultimo
Membro del Collaboration Group
;
2019-01-01
Abstract
The number elderly patients with psoriasis is steadily increasing in the Western world, nevertheless they are frequently excluded from biologic clinical trials and described as a high-risk group for adverse events. Thus, there is lack of information concerning safety and effectiveness of available treatments for psoriasis in the elderly, particularly about new biologic systemic drugs.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
elderly psoriasis JEADV 2018.pdf
Solo gestori archivio
Descrizione: articolo completo
Tipologia:
versione post-print
Dimensione
557.01 kB
Formato
Adobe PDF
|
557.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
